Rating date
Jul 1, 2026
40 days ago
EMR Equity Research — OVERWEIGHT — July 2026
Rating date
Jul 1, 2026
40 days ago
Desk view
OW
5D move
—
Awaiting market data
Peer rank
27p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · EMR
Here is the analysis for EMR (Emerson Electric Co.).
Desk rating
OW
Tactical OW · 12M OW
Horizon
Short to medium term
Confidence
Low
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
OVERWEIGHT
Catalysts
Risks
Price context alongside the research narrative.
Full desk note for Jul 1, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
EMR bias
OVERWEIGHT
Horizon
Short to medium term
EMR key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
EMR catalyst watch
Trend structure is still bullish. EMR's 50-day SMA ($140.62) remains above the 200-day SMA ($137.65), and both are rising. Price has not broken either MA on a closing basis.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
Low
How the call aged · 5D
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-02T20:45:18.368227+00:00.
5D move
—
2026-07-01 → awaiting
Outcome
Awaiting market data
5D trend
-1.36%
Vol (20D ann.)
+34.03%
vs SPY: -3.06%
Close 139.52 → — (USD, vendor closes)
Publish QC
Pipeline fingerprint 2f45a102687f75c0
Trace 120c1ed5…
No QC issues recorded.